Navigation Links
Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
Date:5/16/2008

ed intellectual property licenses from third parties may be required in the future. Other important risks and uncertainties are detailed in Nektar's reports and other filings with the SEC including its most recent Quarterly Report on Form 10-Q filed with the SEC on May 9, 2008. Actual results could differ materially from the forward-looking statements contained in this press release. Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events, or otherwise. No information regarding or presented at the scientific meetings referred to above (or contained at the Internet links provided) is intended to be incorporated by reference in this press release.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com

References and Glossary

(1) Borad, M.J., Hamm, J.T., Rosen, L.S., Jameson, G., Utz, J., Mulay, M.,

Eldon, M., Dhar, S., Acosta, L., Von Hoff, D.D., "Phase 1 Dose-finding

and pharmacokinetic study of NKTR-102 (Pegylated irinotecan): early

evidence of anti-tumor activity"; ASCO 2008 Annual Meeting

Proceedings, May 15, 2008.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... YORK , May 27, 2015 Protein ... source, based on differences in their physical properties. The ... the largest amount of functional protein with fewest contaminants. ... to grow at a CAGR of around 5% to ... driven by increased research in the pharmaceutical and biotechnological ...
(Date:5/27/2015)... 2015  Precision Advisors ( www.precisionadvisors.com ), a Precision ... Digital Trends Study of 145 managed care executives. The ... concepts of big data and predictive analytics, but are ... The Health Information Technology for Economic and Clinical Health ... use of electronic medical records (EMRs) by 2014. While ...
(Date:5/27/2015)... , May 27, 2015 ... announced the addition of the  "US Cancer ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... into to two broad categories of prophylactic ... cancer vaccines belong to both of these ...
Breaking Medicine Technology:Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... Corporation (NYSE: BSX ) announces that ... Stent System demonstrated non-inferior results in treating ... year compared to the PROMUS Element™ Everolimus-Eluting Platinum ... Use Trial.  The trial reported one-year clinical and ...
... May 15, 2012  InfuSystem Holdings, Inc. (NYSE MKT:  INFU), ... services for the healthcare industry, today announced that it ... Monday, May 21, 2012 following the market close.  ... call on Tuesday, May 22, 2012 at 9:00 a.m. ...
Cached Medicine Technology:One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 2One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 3One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 4One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 5One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent 6
(Date:5/27/2015)... Bedford, New Hampshire (PRWEB) May 27, 2015 ... published in the April 2015 issue of the Journal ... of diet sodas and abdominal obesity, Bedford Commons ... consuming water instead of non-nutritive sweetener-flavored beverages. , ... long-term waist circumference, a comprehensive San Antonio Longitudinal Study ...
(Date:5/27/2015)... The MedSpa at Hendrick is excited to ... in Abilene, Texas: Xeomin®, Belotero Balance® and Radiesse®. , ... lines, better known as the lines between the eyebrows ... treat smoker’s lines around the mouth and marionette lines ... the appearance of smile lines or lines around the ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CompanionDx ... pharmacogenomic and somatic genomic analysis in personalized cancer therapy: ... by the American Society of Clinical Oncology (ASCO) as ... 2 in Chicago. , The molecular and clinical data ... Genome Atlas (TCGA) database. The study reports improved patient ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Women’s Health Clinic in ... Foundation is proud to host the first annual Women Veterans ... 11 at the Freedom Center from 6 p.m. to 10 ... emcee. , This event honors and celebrates women tri-state ... The banquet is free to the first 150 women Veterans ...
(Date:5/27/2015)... Rolling Meadows, IL (PRWEB) May 27, 2015 ... the release of its SonarMD Platform, a ... engaging, monitoring and managing patients with chronic ... Lawrence Kosinski, MD, MBA, the application allows ... between visits through the ongoing use of ...
Breaking Medicine News(10 mins):Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
... years or longer before currently available blood tests will detect ... of Medicine scientists indicates. The analysis, which was restricted to ... types, will be published online Nov. 16 in Science ... as both bad and good news," said Sanjiv "Sam" Gambhir, ...
... of Orthopaedic Surgeons (AAOS) Board of Directors has recently ... on "The Treatment of Supracondylar Humerus Fractures." ... of the Trauma Program at the University of Toronto ... AAOS Work Group responsible for this CPG, said that ...
... --- In 2020, the vast majority of adults in America ... suffer from diabetes or pre-diabetic conditions, according to projections presented ... Scientific Sessions Wednesday, Nov. 16, in Orlando. The ... overall heart health by 20 percent in 2020. However, if ...
... a breathtaking technological revolution that promises remarkable new ways ... the release of dangerous nanoparticles, nanorobots or nanoelectronic devices ... review of more than 500 studies on the topic ... ACS, journal Molecular Pharmaceutics . Ruth Duncan ...
... less produce the finest foie gras that rich, buttery ... eaten as slices atop lightly toasted bread scientists are ... and Food Chemistry. Caroline Molette and colleagues explain ... gras, a traditional French dish, comes from its high fat ...
... issues facing lesbian, gay, bisexual and transgender baby boomers ... These seniors face higher rates of disability, physical and ... according to the first study on aging and health ... and led by Karen Fredriksen-Goldsen and colleagues at the ...
Cached Medicine News:Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:On track to getting even fatter 2Health News:On track to getting even fatter 3Health News:LGBT seniors face harder old age, national study finds 2Health News:LGBT seniors face harder old age, national study finds 3
... versatility that a second mirror adds, then you ... It features the same 1.5x magnification as the ... 60 and 64 respectively. Available in standard (flange) ... the "Flanged" model for laser use. ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 15° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
... 15° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
Medicine Products: